Please login to the form below

Not currently logged in
Email:
Password:

Controversial stem cell scientist sentenced

Disgraced scientist, Hwang Woo-suk, has been found guilty of fraud and received a suspended sentence following a lengthy trial

Disgraced scientist, Hwang Woo-suk, was found guilty by a South Korean court of fraud and handed down a suspended sentence on October 26, following a trial that stretched over more than three years. 

Hwang faced charges of fraud, misusing state funds and violating bioethics laws following allegations by an investigation team at Seoul National University in 2005 that his team fabricated vital data in two papers on human embryonic stem cells published in Science magazine. 

Hwang's team achieved recognition in 2004 when it appeared to make two major breakthroughs by cloning stem cells and tailoring them to a specific patient. The findings raised hopes of generating genetically specific tissue to repair damaged organs or treat diseases such as Alzheimer's, which led to Hwang being hailed as a national hero and receiving accolades such as being named one of the world's 100 most influential people in 2004 by Time magazine. 

In 2006 prosecutors charged him with fraud and embezzlement and sought a four year prison term. A total of 40 court hearings have preceded this final verdict and sentencing.

26th October 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics